[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346537-105":59,"doc-detail-346537-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-computational-analysis-of-tp53-exon-5-6-mutations-in-oral-cavity-prostate-and-breast-cancers-in-a-senegalese-population","Integrative Computational Analysis of TP53 Exon 5-6 Mutations in Oral Cavity, Prostate, and Breast Cancers in a Senegalese Population","","Tumor suppressor TP53 is frequently altered in human cancers, yet the mutational landscape and functional consequences of TP53 variants in African populations remain insufficiently defined. This study investigated TP53 exons 5–6 mutations in oral cavity, prostate, and breast cancers from Senegal and evaluated structural and functional effects and consequences for p53–BCL-2 interactions using variant annotation, in silico functional predictors, stability and dynamics modeling, and statistical analyses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-computational-analysis-of-tp53-exon-5-6-mutations-in-oral-cavity-prostate-and-breast-cancers-in-a-senegalese-population/346537/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-computational-analysis-of-tp53-exon-5-6-mutations-in-oral-cavity-prostate-and-breast-cancers-in-a-senegalese-population/346537.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main aim of the study on TP53 exons 5–6?","Question",{"text":112,"@type":113},"To characterize TP53 exon 5–6 mutations in oral cavity, prostate, and breast cancers in a Senegalese population and to assess structural effects, functional consequences, and p53–BCL-2 interaction changes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were TP53 variants annotated and their functional impact evaluated?",{"text":117,"@type":113},"Variants were annotated using COSMIC and dbSNP. Functional impact was assessed with PolyPhen-2, while structural stability changes were predicted with FoldX and conformational dynamics with ENCoM; p53–BCL-2 effects were analyzed using DDMut-PPI.",{"name":119,"@type":110,"acceptedAnswer":120},"Which cancers and exon regions showed notable mutation patterns?",{"text":121,"@type":113},"Breast cancer had the highest TP53 mutation frequency, oral cavity cancer showed greater mutational diversity, and exon-level analysis enriched exon 6 mutations in breast cancer. Exon 5 mutations were mainly destabilizing with loss-of-function effects, while recurrent exon 6 mutations in prostate and breast cancers, including V217L and V218M, were predicted to stabilize p53.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346537,1790439435,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Article  \nIntegrative Computational Analysis of TP53 Exon 5–6 Mutations in Oral Cavity, Prostate, and Breast Cancers in a  \nSenegalese Population  \nMouhamed Mbaye 1, Fatimata Mbaye 2,* and Mbacke Sembene 2  \nAcademic Editor: Ilya Ioshikhes  \nReceived: 20 January 2026  \nRevised: 3 February 2026  \nAccepted: 6 February 2026  \nPublished: 20 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Pharmaceutical Biophysics Laboratory, Department of Pharmacy, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar BP. 5005, Senegal; [mouhamed19.mbaye@ucad.edu.sn](mouhamed19.mbaye@ucad.edu.sn)  \n2 Genomics Laboratory, Department of Animal Biology, Faculty of Science and Technology, Cheikh Anta Diop University, Dakar BP. 5005, Senegal; [mbacke.sembene@ucad.edu.sn](mbacke.sembene@ucad.edu.sn)  \n* Correspondence: [fatimata2.mbaye@ucad.edu.sn](fatimata2.mbaye@ucad.edu.sn)  \nAbstract  \nBackground/Objectives: The tumor suppressor gene TP53 is one of the most frequently mutated genes inhuman cancers, with alterations predominantly affecting its DNA-binding domain (DBD) . However, the mutational landscape and functional consequences of TP53 variants remain poorly characterized in African populations. This study aimed to characterize mutations in exons 5–6 of TP53 in oral cavity cancer (OCC), prostate cancer (PC), and breast cancer (BC) in a Senegalese population, and to assess their structural effects, functional consequences, and impact on protein–protein interactions with BCL-2 . Methods: Seventy-eight archived tumor DNA samples from Senegalese patients with OCC, PC, and BC were analyzed. Variants were annotated using COSMIC and dbSNP databases. Functional impact was evaluated with PolyPhen-2 . Structural stability changes (∆∆G) were predicted using FoldX, conformational dynamics (∆∆Svib) were assessed with ENCoM, and effects on the p53–BCL-2 interaction were analyzed using DDMut-PPI. Statistical analyses were also performed. Results: BC exhibited the highest TP53 mutation frequency, whereas OCC showed greater mutational diversity. Exon-level analysis revealed a significant enrichment of exon 6 mutations in BC. Structural analyses indicated that exon 5 mutations across all cancers and mutations in OCC were predominantly destabilizing and associated with loss-of-function effects. In contrast, recurrent exon 6 mutations in PC and BC, particularly V217L and V218M, were predicted to stabilize the p53 structure. Conformational dynamics differences between exons were significant only in PC. All analyzed mutations were predicted to stabilize the p53–BCL-2 interaction. Conclusions: This integrative insilico study identified cancer and exon-specific TP53 mutation patterns in a Senegalese population, highlighting exon 6 as a context-dependent hotspot with potential oncogenic implication in PC and BC. Despite its computational nature, the study provides valuable insights that merit further investigation.  \nKeywords: TP53; cancer; oral cavity; prostate; breast; Senegal; mutation; bioinformatics  \n1. Introduction  \nAlthough not all cancers are initiated by detectable gene mutations, cancer development generally involves a complex interplay of genetic and epigenetic alterations, environmental exposures, and cellular stress [1] . Among the genes most frequently affected, TP53  \nstands out as the single most mutated gene in human cancers, with alterations identified in approximately 50% of solid tumors [2] . TP53 encodes the tumor suppressor protein p53, a transcription factor central to maintaining genomic integrity through its roles in DNA repair, cell cycle arrest, senescence, and apoptosis [3]. Mutations affecting the DNA-binding domain (DBD), which spans exons 5 to 8, are particularly disruptive, as this region is essential for sequence-specific DNA recognition ","cbCaiiojX9ooZq8Q","https://ap.wps.com/l/cbCaiiojX9ooZq8Q","pdf",2084153,17,"English","# Abstract\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the main aim of the study on TP53 exons 5–6?\",\"answer\":\"To characterize TP53 exon 5–6 mutations in oral cavity, prostate, and breast cancers in a Senegalese population and to assess structural effects, functional consequences, and p53–BCL-2 interaction changes.\"},{\"question\":\"How were TP53 variants annotated and their functional impact evaluated?\",\"answer\":\"Variants were annotated using COSMIC and dbSNP. Functional impact was assessed with PolyPhen-2, while structural stability changes were predicted with FoldX and conformational dynamics with ENCoM; p53–BCL-2 effects were analyzed using DDMut-PPI.\"},{\"question\":\"Which cancers and exon regions showed notable mutation patterns?\",\"answer\":\"Breast cancer had the highest TP53 mutation frequency, oral cavity cancer showed greater mutational diversity, and exon-level analysis enriched exon 6 mutations in breast cancer. Exon 5 mutations were mainly destabilizing with loss-of-function effects, while recurrent exon 6 mutations in prostate and breast cancers, including V217L and V218M, were predicted to stabilize p53.\"}]","Integrative Computational Analysis of TP53 Exon 5-6 Mutations in Oral Cavity, Prostate, and Breast Cancers in a Senegalese Population | PDF",1790061882,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd8b147e8f2434afd70b5e79cbc42509.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c46ca5dc6dc5735dda13375f9e3dc495.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4108eba9e52d34bcd317445c2eb13f5.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a30799ad768438914b6b11fd3d5c7c1.webp",980,1385]